Pharmaceutical

Takeda Pharmaceutical Stock: Mixed Signals and Outlook
Clinical & Pharma Takeda Pharmaceutical Stock: Mixed Signals and Outlook

In the ever-shifting landscape of the pharmaceutical industry, Takeda Pharmaceutical Co ADR (TAK) stands as a notable contender, drawing significant attention from investors navigating the complexities of the stock market. With a market capitalization of $44.28 billion and a workforce of over

Can Trump Force Big Pharma to Slash US Drug Prices?
Clinical & Pharma Can Trump Force Big Pharma to Slash US Drug Prices?

Imagine a scenario where the cost of life-saving medications in the United States drops dramatically overnight, easing the financial burden on millions of families who struggle to afford essential drugs. This vision is at the heart of a recent bold move by President Donald Trump, who has directly

Why Is Teva Pharma Stock Rising After Q2 2025 Results?
Clinical & Pharma Why Is Teva Pharma Stock Rising After Q2 2025 Results?

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has captured the attention of investors with a notable uptick in its stock price following the release of its second-quarter financial results, which showed a mix of challenges and successes. On Wednesday, the stock surged by 2.36% to $16.94, a

Why Are ADHD Prescriptions Soaring in England?
Clinical & Pharma Why Are ADHD Prescriptions Soaring in England?

In England, the landscape of ADHD diagnoses and prescriptions has markedly shifted, reflecting growing awareness and changing societal attitudes toward the condition. Over the decade, ADHD diagnoses have surged as individuals and healthcare systems increasingly recognize the symptoms of this

West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results
Clinical & Pharma West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results

West Pharmaceutical Services has experienced significant financial success, with a notable 23.15% increase in its stock price, reaching $279.26. This surge is primarily driven by a higher-than-expected earnings report, surpassing Wall Street projections and signaling robust demand for its products.

Will Africa's Pharma Market Hit $118 Billion by 2032?
Clinical & Pharma Will Africa's Pharma Market Hit $118 Billion by 2032?

Africa's pharmaceutical market is on the cusp of a transformative era, projected to expand from USD 64.2 billion in 2025 to USD 118.3 billion by 2032, at an impressive CAGR of 9.10%. The surge in this sector is largely attributed to an increase in chronic disease cases, improvements in regulatory

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later